Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Repeated scanning ultrasound in the absence of a therapeutic agent removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results support previous studies showing improved behaviour in AD mouse models associated with enhanced microglial amyloid plaque phagocytosis in response to scanning ultrasound69, and treatment with IL-33 that signals exclusively via MyD8870.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [69]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“An entire series of sections was processed for Campbell-Switzer silver staining (36) using a protocol available online at http://neuroscienceassociates.”
MethodScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Ab is elevated in the AD brain because of the increased production of this peptide and its impaired removal (4, 5).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“At the age of 12 to 13 months, APP23 mice have a substantial plaque burden and spatial memory deficits (17).”
BackgroundSelf-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“Recent therapeutic strategies have targeted both processes (6), including the inhibition of secretase enzymes to reduce Ab production, as well as active and, in particular, passive immunization approaches for boosting Ab clearance.”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · cited 1×
“Inhibition of secretases affects additional substrates with potential off-target effects (7), and passive immunization may be costly once effectiveness is demonstrated in clinical trials (8).”
Background
Cited by
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04529-6 · Cited by 950
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Carpentier, A., Canney, M., Vignot, A., Reina, V., Beccaria, K., Horodyckid, C., Karachi, C., Leclercq, D., Lafon, C., Chapelon, J.-Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6086 · Cited by 757
“However, because of induced glial and immune reactions observed in animal studies (24), a ~5-cm(3) BBB disruption treatment volume with our device was considered an important achievement, especially if it acts as an “opened gate” for potential locoregional efficacy (14).”
BackgroundOvercoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695
“Downloaded from https://academic.oup.com/brain/article-abstract/139/4/1265/2464332 by guest on 27 July 2018”
BackgroundMethodNguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
Self-citationNeuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Meng, Y., Hynynen, K., & Lipsman, N. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00418-z · Cited by 505
Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer
Canavese, G., Ancona, A., Racca, L., Canta, M., Dumontel, B., Barbaresco, F., Limongi, T., & Cauda, V. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.01.060 · Cited by 457
“Moreover, HIFU was also proposed as a novel approach capable to ablate heart ectopic foci and to obtain hemostasis in acute traumatic injuries [7] and for the treatment of Alzheimer disease [43].”
BackgroundDisrupting the blood–brain barrier by focused ultrasound induces sterile inflammation
Kovacs, Z. I., Kim, S., Jikaria, N., Qureshi, F., Milo, B., Lewis, B. K., Bresler, M., Burks, S. R., & Frank, J. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614777114 · Cited by 458
“Moreover, the presence of inflammatory cytokines may contribute to the expression of BDNF, EPO, and VEGF in our study and could explain the enhanced neurogenesis observed in AD models (38, 40).”
BackgroundMarsh, S. E., Abud, E. M., Lakatos, A., Karimzadeh, A., Yeung, S. T., Davtyan, H., Fote, G. M., Lau, L., Weinger, J. G., Lane, T. E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525466113 · Cited by 411
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Polanco, J. C., Li, C., Bodea, L.-G., Martinez-Marmol, R., Meunier, F. A., & Götz, J. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 378
Self-citationUltrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery
Kooiman, K., Roovers, S., Langeveld, S. A. G., Kleven, R. T., Dewitte, H., O'Reilly, M. A., Escoffre, J.-M., Bouakaz, A., Verweij, M. D., Hynynen, K., et al. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.01.002 · Cited by 359
Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai, A. R., Ranjan, M., D’Haese, P.-F., Haut, M. W., Carpenter, J., Najib, U., Mehta, R. I., Chazen, J. L., Zibly, Z., Yates, J. R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002571117 · Cited by 365
“FUS-mediated BBB opening in preclinical models has been found to promote amyloid-beta clearance, delivery of endogenous antibodies, activation of microglia (8, 12), and potential modulation of the glymphatic system (13).”
BackgroundTranscriptional signature in microglia associated with Aβ plaque phagocytosis
Grubman, A., Choo, X. Y., Chew, G., Ouyang, J. F., Sun, G., Croft, N. P., Rossello, F. J., Simmons, R., Buckberry, S., Landin, D. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23111-1 · Cited by 357
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
The identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308
Krishna, V., Sammartino, F., & Rezai, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3129 · Cited by 289
Ultrasound treatment of neurological diseases — current and emerging applications
Leinenga, G., Langton, C., Nisbet, R., & Götz, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.13 · Cited by 275
Self-citationTau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272
Self-citationBeisteiner, R., Matt, E., Fan, C., Baldysiak, H., Schönfeld, M., Philippi Novak, T., Amini, A., Aslan, T., Reinecke, R., Lehrner, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201902583 · Cited by 269
Drug and gene delivery across the blood–brain barrier with focused ultrasound
Timbie, K. F., Mead, B. P., & Price, R. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.059 · Cited by 227
“Alzheimer's Leinenga, 2015 APP23 Mice NA Unencapsulated [69]”
MethodRecent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
Hane, F. T., Robinson, M., Lee, B. Y., Bai, O., Leonenko, Z., & Albert, M. S. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160907 · Cited by 197
“In wild-type littermates, rapamycin did not reduce endogenous A , but still improved learning and retention; therefore, it is likely that rapamycin and the TOR signaling pathway are involved in multiple processes that are important in aging and AD [100].”
BackgroundA review of low-intensity focused ultrasound for neuromodulation
Baek, H., Pahk, K. J., & Kim, H. (2017) · Biomedical Engineering Letters · doi:10.1007/s13534-016-0007-y · Cited by 184
Nisbet, R. M., Van der Jeugd, A., Leinenga, G., Evans, H. T., Janowicz, P. W., & Götz, J. (2017) · Brain · doi:10.1093/brain/awx052 · Cited by 187
“All animals were anaesthetized and prepared as previously described (Leinenga and Götz, 2015).”
InfluentialSelf-citationChen, K.-T., Wei, K.-C., & Liu, H.-L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00086 · Cited by 164
“The multidirectional responses from different components (i.e., microglial activation) of the therapeutic area offer an opportunity to change the microenvironment and immunogenicity, which might be beneficial for disease control (Leinenga and Gotz, 2015).”
BackgroundInfluentialDeng, Z., Wang, J., Xiao, Y., Li, F., Niu, L., Liu, X., Meng, L., & Zheng, H. (2021) · Theranostics · doi:10.7150/thno.52436 · Cited by 168
“Ultrasound stimulation has shown great potential in AD therapy in animal models [19, 20].”
Gouveia-Freitas, K., & Bastos-Leite, A. J. (2021) · Neuroradiology · doi:10.1007/s00234-021-02718-7 · Cited by 159
“Such enhanced β-amyloid clearance was found to be associated with improvement of memory and behavioural measures [113, 114].”
BackgroundNon-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Niazi, S. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112599 · Cited by 168
“Using focused ultrasound combined with microbubbles, research has demonstrated the potential to temporarily open the BBB and assist in the clearance of these plaques, showcasing potential therapeutic benefits [68].”
BackgroundNoninvasive and targeted delivery of therapeutics to the brain using focused ultrasound
Poon, C., McMahon, D., & Hynynen, K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.014 · Cited by 148
“…IBA1 (microglia) No degenerating neurons, edema, or RBC extravasation No ischemic damage Microglial activation, but no astrogliosis, at one an 24 h after sonication *Leinenga and G€otz 2015 e Scanning ultrasound removes Aß and restores memory in an AD mouse model Rhesus macaque 0.5 MHz 0.3e0.”
InfluentialApplications of focused ultrasound-mediated blood-brain barrier opening
Gorick, C. M., Breza, V. R., Nowak, K. M., Cheng, V. W. T., Fisher, D. G., Debski, A. C., Hoch, M. R., Demir, Z. E. F., Tran, N. M., Schwartz, M. R., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114583 · Cited by 144
Exploiting the mechanical effects of ultrasound for noninvasive therapy
O’Reilly, M. A. (2024) · Science · doi:10.1126/science.adp7206 · Cited by 169
Current and emerging avenues for Alzheimer's disease drug targets
Loera‐Valencia, R., Cedazo‐Minguez, A., Kenigsberg, P. A., Page, G., Duarte, A. I., Giusti, P., Zusso, M., Robert, P., Frisoni, G. B., Cattaneo, A., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12959 · Cited by 141
Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy
Hynynen, K., & Jones, R. M. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/17/r206 · Cited by 157
“…of these agents can be effective in animal disease models, with huge potential for treating brain tumors (Liu et al 2010, Treat et al 2012, Aryal et al 2013), Alzheimer’s disease (Burgess et al 2014, Leinenga and Götz 2015), and Parkinson’s disease (Samiotaki et al 2015), just to name a few.”
BackgroundMcMahon, D., Bendayan, R., & Hynynen, K. (2017) · Scientific Reports · doi:10.1038/srep45657 · Cited by 138
Belcik, J. T., Davidson, B. P., Xie, A., Wu, M. D., Yadava, M., Qi, Y., Liang, S., Chon, C. R., Ammi, A. Y., Field, J. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024826 · Cited by 138
Acoustic Streaming and Its Applications
Wu, J. (2018) · Fluids · doi:10.3390/fluids3040108 · Cited by 139
“streaming field generated by a single ultrasound transducer [48]; it resembles the acoustic streaming field observed by Nowicki et al.”
InfluentialWu, S.-Y., Aurup, C., Sanchez, C. S., Grondin, J., Zheng, W., Kamimura, H., Ferrera, V. P., & Konofagou, E. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25904-9 · Cited by 125
“(5) The monitoring transducer for acoustic mapping was aligned to the FUS focus before sonication with neuronavigation guidance.”
MethodThe Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease
Czapski, G. A., Czubowicz, K., Strosznajder, J. B., & Strosznajder, R. P. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1776-x · Cited by 131
“Additionally, the heterogeneity of individual inflammatory response must also be analyzed [144, 145].”
BackgroundJones, R. M., Deng, L., Leung, K., McMahon, D., O'Reilly, M. A., & Hynynen, K. (2018) · Theranostics · doi:10.7150/thno.24911 · Cited by 129
“Extensive pre-clinical work has shown that a wide range of therapeutic agents can be delivered to brain parenchyma using the aforementioned approach [4-6], and improved outcomes have been demonstrated in animal models of brain tumors [7-9] and Alzheimer's disease [10-13].”
BackgroundMicroglia in Alzheimer’s disease: A multifaceted relationship
ElAli, A., & Rivest, S. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.021 · Cited by 134
“This study showed that SUS increased BBB permeability in a transient manner, which allowed the entry of bloodborne molecules sufficiently to activate microglia, such as albumin, without eliciting an excessive inflammatory response, or triggering the infiltration of BMDMs into the brain (Leinenga and Götz, 2015), These…”
BackgroundKlibanov, A. L., & Hossack, J. A. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000188 · Cited by 129
“Expansion of this technique toward clinical applications could be predicted, ranging from tumor therapy(174) to Alzheimer treatment.(175,176) Similar therapeutic approach can be applied in the situations other than the blood-brain barrier, to any endothelial lining in the vasculature that precludes entry of the drug i…”
BackgroundAcoustically targeted chemogenetics for the non-invasive control of neural circuits
Szablowski, J. O., Lee‐Gosselin, A., Lue, B., Malounda, D., & Shapiro, M. G. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0258-2 · Cited by 132
Cho, H., Lee, H.-Y., Han, M., Choi, J.-R., Ahn, S., Lee, T., Chang, Y., & Park, J. (2016) · Scientific Reports · doi:10.1038/srep31201 · Cited by 120
Lee, Y., Choi, Y., Park, E.-J., Kwon, S., Kim, H., Lee, J. Y., & Lee, D. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-73151-8 · Cited by 123
Fan, C.-H., Ting, C.-Y., Lin, C., Chan, H.-L., Chang, Y.-C., Chen, Y.-Y., Liu, H.-L., & Yeh, C.-K. (2016) · Scientific Reports · doi:10.1038/srep19579 · Cited by 114
Todd, N., Angolano, C., Ferran, C., Devor, A., Borsook, D., & McDannold, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.040 · Cited by 112
Amar, F., Sherman, M. A., Rush, T., Larson, M., Boyle, G., Chang, L., Götz, J., Buisson, A., & Lesné, S. E. (2017) · Science Signaling · doi:10.1126/scisignal.aal2021 · Cited by 112
Self-citationRetractedPandit, R., Leinenga, G., & Götz, J. (2019) · Theranostics · doi:10.7150/thno.34388 · Cited by 114
“for microglia in the phagocytosis of amyloid-β plaques [21, 31].”
BackgroundResultInfluentialSelf-citationCavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening
Ji, R., Karakatsani, M. E., Burgess, M., Smith, M., Murillo, M. F., & Konofagou, E. E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.042 · Cited by 109
Rezai, A. R., Ranjan, M., Haut, M. W., Carpenter, J., D’Haese, P.-F., Mehta, R. I., Najib, U., Wang, P., Claassen, D. O., Chazen, J. L., et al. (2023) · Journal of Neurosurgery · doi:10.3171/2022.9.jns221565 · Cited by 111
“11,17,41 The exact mechanism of FUS-mediated β -amyloid reduction is unknown and is an area of active investigation.”
Curley, C. T., Sheybani, N., Bullock, T. N. J., & Price, R. J. (2017) · Theranostics · doi:10.7150/thno.21225 · Cited by 115
“Indeed, ultrasound treatment has shown reduced plaque load in two studies utilizing different transgenic mouse models[39,52].”
BackgroundUltrasound in tumor immunotherapy: Current status and future developments
Ho, Y.-J., Li, J.-P., Fan, C., Liu, H.-L., & Yeh, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.023 · Cited by 119
Expression of Concern: Focused transcranial ultrasound for treatment of neurodegenerative dementia
Nicodemus, N., Becerra, S. A., Kuhn, T. P., Packham, H., Duncan, J., Mahdavi, K. D., Iovine, J., Kesari, S., Pereles, S., Whitney, M., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.007 · Cited by 110
Advanced Ultrasound Technologies for Diagnosis and Therapy
Rix, A., Lederle, W., Theek, B., Lammers, T., MOONEN, C. T. W., Schmitz, G., & Kiessling, F. M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200030 · Cited by 117
“Additionally, focused ultrasound was shown to decrease Alzheimer-related plaque development in the brains of animals—an effect that was also tentatively attributed to immune system stimulation (35).”
Blood-brain barrier disruption: a culprit of cognitive decline?
Che, J., Sun, Y., Deng, Y., & Zhang, J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00563-3 · Cited by 124
O'Reilly, M. A., Hough, O., & Hynynen, K. (2017) · Journal of Ultrasound in Medicine · doi:10.7863/ultra.16.02005 · Cited by 95
Antidepressant-Like Effect of Low-Intensity Transcranial Ultrasound Stimulation
Zhang, D., Li, H., Sun, J., Hu, W., Jin, W., Li, S., & Tong, S. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2018.2845689 · Cited by 106
“[16], [17], epilepsy [18], and Alzheimer’s disease [19], [20].”
Karakatsani, M. E., Kugelman, T., Ji, R., Murillo, M., Wang, S., Niimi, Y., Small, S. A., Duff, K. E., & Konofagou, E. E. (2019) · Theranostics · doi:10.7150/thno.28717 · Cited by 98
“FUS applied within the safety regime has been proven beneficial [26,35,53] while vascular incidences have been reported in sonication protocols involving overlapping regions and repeated applications [43].”
BackgroundInfluentialShen, Y., Hua, L., Yeh, C.-K., Shen, L., Ying, M., Zhang, Z., Liu, G., Li, S., Chen, S., Chen, X., et al. (2020) · Theranostics · doi:10.7150/thno.44152 · Cited by 96
“7 MPa, 10% duty cycle at 1 Hz) over 6–7 weeks on the entire brain displayed improved performance on three memory tasks: the Y-maze, the novel object recognition test and the active place avoidance task [16].”
BackgroundMethodInfluentialOptimized ultrasound neuromodulation for non-invasive control of behavior and physiology
Murphy, K. R., Farrell, J. S., Bendig, J., Mitra, A., Luff, C., Stelzer, I. A., Yamaguchi, H., Angelakos, C. C., Choi, M., Bian, W.-J., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.07.002 · Cited by 111
Shen, Y., Pi, Z., Yan, F., Yeh, C., Zeng, X., Diao, X., Hu, Y., Chen, S., Chen, X., & Zheng, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s136401 · Cited by 104
“46 Further investigation by Kovacs et al clearly demonstrated that pulsed FUS with MBs could induce the production of cytokines, chemokines and trophic factors linking to microglial activation.”
Bobola, M. S., Chen, L., Ezeokeke, C. K., Olmstead, T., Nguyen, C., Sahota, A., Williams, R. G., & Mourad, P. D. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.03.016 · Cited by 107
“This reduction in Ab burden compares to that achieved by Leinenga and Gotz [9], who used ultrasound plus acoustic contrast agents to disrupt the blood-brain barrier in an intermittent fashion over a period of two months.”
MethodResultInfluentialPassive Acoustic Mapping with the Angular Spectrum Method
Arvanitis, C., Crake, C., McDannold, N. J., & Clement, G. T. (2016) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2643565 · Cited by 97
“2643565 deposition can be used to deliver drugs [7]–[9], fractionate tissue [2], lyse blood clots [10], amplify circulating biomarkers [11] and even remove amyloid plaque [12] and activate neuronal networks [13].”
Leinenga, G., Koh, W. K., & Götz, J. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00809-4 · Cited by 97
Self-citationPark, S. H., Baik, K., Jeon, S., Chang, W. S., Ye, B. S., & Chang, J. W. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00269-8 · Cited by 95
McMahon, D., Poon, C., & Hynynen, K. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1567490 · Cited by 94
“Surface cortical structures [30,44,47,48] and deep brain structures, such as the hippocampus [43] and basal ganglia [35], have been successfully targeted”
BackgroundDubey, S., Heinen, S., Krantic, S., McLaurin, J., Branch, D. R., Hynynen, K., & Aubert, I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908658117 · Cited by 94
Shin, J., Kong, C., Lee, J., Choi, B. Y., Sim, J., Koh, C. S., Park, M., Na, Y. C., Suh, S. W., Chang, W. S., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0569-x · Cited by 92
Power cavitation-guided blood-brain barrier opening with focused ultrasound and microbubbles
Burgess, M. T., Apostolakis, I., & Konofagou, E. E. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aab05c · Cited by 92
“Additionally, BBB opening alone has been shown to stimulate an immunological response in the brain to ameliorate neurological disease progression, therefore serving as a non-pharmacological treatment modality (Leinenga and Götz 2015).”
Mann, A., Gondard, E., Tampellini, D., MILSTED, J. A. T., Marillac, D., Hamani, C., Kalia, S. K., & Lozano, A. M. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.11.012 · Cited by 98
Baek, H., Lockwood, D. S., Mason, E. J., Obusez, E. C., Poturalski, M. J., Rammo, R. A., Nagel, S. J., & Jones, S. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.880814 · Cited by 98
“However, even without these therapeutics, studies have reported that BBB opening alone triggers a significant reduction of Aβ deposition through microglia activation (98, 99).”
BackgroundNon-invasive ultrasonic neuromodulation of neuronal excitability for treatment of epilepsy
Lin, Z., Meng, L., Zou, J., Zhou, W., Huang, X., Xue, S. Y., Bian, T., Yuan, T., Niu, L., Guo, Y., et al. (2020) · Theranostics · doi:10.7150/thno.40520 · Cited by 91
“The ultrasound waves can penetrate the intact skull to specific brain regions, causing modulatory effects of neuronal activity or behavioral outcome [20-29].”
BackgroundOikari, L. E., Pandit, R., Stewart, R., Cuní-López, C., Quek, H., Sutharsan, R., Rantanen, L. M., Oksanen, M., Lehtonen, S., de Boer, C. M., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.011 · Cited by 90
“…after ultrasound) and cells were tested under four conditions: (1) UT, (2) MB control, (3) US control, and (4) test condition (US + MB), which received both ultrasound and MBs. MBs were prepared as described previously (Leinenga and Götz, 2015) and added to the wells aseptically (10 mL per well).”
BackgroundMethodSelf-citationCurrent status and future perspectives of sonodynamic therapy in glioma treatment.
Wang, X., Jia, Y., Wang, P., Liu, Q., & Zheng, H. (2017) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2017.02.020 · Cited by 86
Xhima, K., Nabbouh, F., Hynynen, K., Aubert, I., & Tandon, A. (2018) · Movement Disorders · doi:10.1002/mds.101 · Cited by 89
Hopperton, K. E., Trépanier, M.-O., Giuliano, V., & Bazinet, R. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0721-5 · Cited by 78
“No significant differences between the groups were identified for the number of microglia process end points per cell, used here and previously as an indicator of the number of branches per cell [58, 59], in the CA1 or DG.”
BackgroundMethodResultPouliopoulos, A. N., Kwon, N., Jensen, G., Meaney, A., Niimi, Y., Burgess, M. T., Ji, R., McLuckie, A. J., Munoz, F. A., Kamimura, H. A. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94188-3 · Cited by 85
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 81
Yıldırım, A., Chattaraj, R., Blum, N. T., & Goodwin, A. P. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b02634 · Cited by 91
Clark, I. A., & Vissel, B. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13181 · Cited by 84
Poon, C. T., Shah, K., Lin, C., Tse, R., Kim, K. K., Mooney, S., Aubert, I., Stefanovic, B., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32250-3 · Cited by 79
Therapeutic Agent Delivery Across the Blood–Brain Barrier Using Focused Ultrasound
McMahon, D., O’Reilly, M. A., & Hynynen, K. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121238 · Cited by 93
“Likewise, macrophage infiltration, as assessed by hematoxylin and eosin (52, 55-57) and CD68 immunodetection (54, 58, 59), has been reported weeks (52, 54) following sonication; however, at lower PNPs, it is possible to achieve BBB permeability enhancement with no or few macrophages evident in…”
George, C., Gontier, G., Lacube, P., François, J.-C., Holzenberger, M., & Aïd, S. (2017) · Brain · doi:10.1093/brain/awx132 · Cited by 84
“Total length per microglia was determined in motor cortex using AnalyzeSkeleton (ImageJ) (Leinenga and Götz, 2015).”
MethodJanowicz, P. W., Leinenga, G., Götz, J., & Nisbet, R. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45577-2 · Cited by 76
Self-citationBelkacem, A. N., Jamil, N., Khalid, S., & Alnajjar, F. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1085173 · Cited by 80
Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease
Fishman, P. S., & Frenkel, V. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0515-1 · Cited by 84
“One of the animal studies demonstrated how moving the target of sonication through the brain (scanning FUS) could be a potential useful strategy for treatment of a large brain volume [113].”
BackgroundStriatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study
Pineda‐Pardo, J. A., Gasca‐Salas, C., Fernández‐Rodríguez, B., Rodríguez‐Rojas, R., del Álamo, M., Obeso, I., Hernández‐Fernández, F., Trompeta, C., Martínez‐Fernández, R., Matarazzo, M., et al. (2022) · Movement Disorders · doi:10.1002/mds.29134 · Cited by 75
Focused Ultrasound Combined with Microbubbles in Central Nervous System Applications
Chen, K., Wei, K., & Liu, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071084 · Cited by 88
Non-invasive transcranial brain modulation for neurological disorders treatment: A narrative review
Mosilhy, E. A., Alshial, E. E., Eltaras, M. M., Rahman, M. M. A., Helmy, H. I., Elazoul, A. H., Hamdy, O., & Mohammed, H. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120869 · Cited by 85
Pandit, R., Koh, W. K., Sullivan, R. K. P., Palliyaguru, T., Parton, R. G., & Götz, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.015 · Cited by 72
Self-citationBurks, S. R., Kersch, C. N., Witko, J. A., Pagel, M. A., Sundby, M., Muldoon, L. L., Neuwelt, E. A., & Frank, J. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021915118 · Cited by 77
“The SIR following pFUS+MB BBBD activates microglia, resulting in increased clearance of Αβ plaques (96, 102, 103).”
BackgroundMeng, Y., MacIntosh, B. J., Shirzadi, Z., Kiss, A., Bethune, A., Heyn, C., Mithani, K., Hamani, C., Black, S. E., Hynynen, K., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.060 · Cited by 73
Ultrasound as a versatile tool for short- and long-term improvement and monitoring of brain function
Blackmore, D. G., Razansky, D., & Götz, J. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.018 · Cited by 78
Self-citationGopalan, D., Pandey, A., Udupa, N., & Mutalik, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.034 · Cited by 72
Mehta, R. I., Carpenter, J. S., Mehta, R. I., Haut, M. W., Wang, P., Ranjan, M., Najib, U., D’Haese, P.-F., & Rezai, A. R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00447-y · Cited by 74
Magnin, R., Rabusseau, F., Salabartan, F., Mériaux, S., Aubry, J., Bihan, D. L., Dumont, E., & Larrat, B. (2015) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-015-0044-5 · Cited by 74
“For example, this could be helpful to perform therapeutic proof of concept studies on pathologies affecting the whole CNS, such as Alzheimer’s disease, for which repeated BBB permeabilization over large regions of the brain have recently shown a great potential [17, 22].”
BackgroundKovacs‐Balint, Z., Tu, T., Sundby, M., Qureshi, F. M., Lewis, B. K., Jikaria, N. R., Burks, S. R., & Frank, J. A. (2018) · Theranostics · doi:10.7150/thno.24512 · Cited by 76
“Clearing of Aβ plaques has also been demonstrated with pFUS+MB-mediated BBBD alone based on the hypothesis that endogenous antibodies enter into the targeted parenchyma, facilitating phagocytosis by activated microglia [7, 23, 37, 38].”
BackgroundMethodResultInfluential
Metadata
- Authors
- Leinenga, G., & Götz, J.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Götz, Jürgen
- Venue
- Science Translational Medicine
- Published
- 2015-03-11
- Volume
- 7
- Issue
- 278
- Pages
- 278ra33-278ra33
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2169076271
- Cited by
- 498
- References
- 40
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 40 · 2023: 50 · 2022: 41 · 2021: 52 · 2020: 51 · 2019: 40 · 2018: 44 · 2017: 55 · 2016: 36 · 2015: 25
- FWCI
- 39.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council (DP130101932)
- National Health and Medical Research Council of Australia (APP1037746, APP1003150)
- ARC Linkage Infrastructure, Equipment, and Facilities (LE130100078)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, non-pharmacological treatment, amyloid plaque clearance, microglia, memory recovery, mouse model
- MeSH terms
- Albumins, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Count, Disease Models, Animal, Humans, Inflammation, Lysosomes, Memory, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Ultrasonography, Ultrasonics, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.